1-5 of 5
Frank Morschhauser
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy

Matthew G. Mei, Gaetano Corazzelli, Frank Morschhauser, Elizabeth Phillips, Graham P. Collins, Hun Ju Lee, Steve M Ansell, Craig H. Moskowitz, Nathalie A. Johnson, John Kuruvilla, Martin Hutchings, María José Terol Castera, George Hawkins, Anna Vossenkaemper, Teresa Collins, Robin Lesley, Emma Dean, Ting Yu, Connor Hall, Virginie Cerec, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2023-180926
Published: 2023
Journal Articles

PET4 Response As an Independent Predictor of Long-Term Outcomes in ECHELON2 (A+CHP Vs. CHOP) in CD30+PTCL

Swami P. Iyer, Neha Mehta-Shah, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Frank Morschhauser, EVA Domingo Domenech, Chiara Pagani, Won Seog Kim, Onder Alpdogan, Cheolwon Suh, Tatyana Feldman, Hervé Tilly, Pier Luigi Zinzani, Alessandro Rambaldi, David Belada, Jiri Mayer, Ilseung Choi, June-Won Cheong, Shweta Jain, Fenton Keenan, Michelle A. Fanale, Kerry J. Savage, Steven M. Horwitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3074.
https://doi.org/10.1182/blood-2023-184933
Published: 2023
Journal Articles

An Externally Controlled Trial to Indirectly Compare Tazemetostat Plus Lenalidomide and Rituximab Versus Lenalidomide and Rituximab after at Least One Prior Systemic Therapy in Patients with Refractory and Relapsed Follicular Lymphoma

Loretta J. Nastoupil, Gilles Salles, John P. Leonard, Frank Morschhauser, Kylee Jordan Veazey, Valerie Perrot, Vitalii Doban, Marion Bonnet, Alexandra Z. Sosinsky, Aaron Crowley, Camryn Lieb, Zhengfan Wang, Bret Zeldow, Joanna Harton, Shu Wang, Tamer Garawin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4410.
https://doi.org/10.1182/blood-2023-181807
Published: 2023
Journal Articles

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome

Bruno Chetaille, François Bertucci, Pascal Finetti, Benjamin Esterni, Aspasia Stamatoullas, Jean Michel Picquenot, Marie Christine Copin, Frank Morschhauser, Olivier Casasnovas, Tony Petrella, Thierry Molina, Anne Vekhoff, Pierre Feugier, Reda Bouabdallah, Daniel Birnbaum, Daniel Olive, Luc Xerri
Journal: Blood
Blood (2009) 113 (12): 2765–3775.
https://doi.org/10.1182/blood-2008-07-168096
Published: 2009
Includes: Supplemental data
Journal Articles

Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.

Christophe Ferme, MD, Marine Diviné, MD, Andrej Vranovsky, MD, Frank Morschhauser, MD, Réda Bouabdallah, MD, Jean Gabarre, MD, Aspasia Bastard-Stamatoullas, MD, Richard Delarue, MD, Vittorina Zagonel, MD, Jérôme Jaubert, MD, Anton Hagenbeek, MD, Mark Henri H. Kramer, MD, Chantal Rieux, José Thomas, MD, Michel Henry-Amar, MD
Journal: Blood
Blood (2005) 106 (11): 813.
https://doi.org/10.1182/blood.V106.11.813.813
Published: 2005